emerg
resist
influenza
virus
highlight
continu
requir
new
antivir
drug
treat
viral
infect
nonstructur
protein
indispens
compon
effici
viru
replic
use
potenti
target
gener
new
antivir
agent
studi
interact
monoclon
antibodi
protein
also
determin
whether
influenza
viru
replic
inhibit
block
bind
fragment
fab
form
multimer
complex
rnabind
domain
rbd
residu
form
direct
hydrogen
bond
doubl
strand
rna
protein
found
critic
interact
antibodi
rbd
high
affin
k
nm
wherea
rbd
time
lower
affin
toward
interestingli
intracellular
express
variabl
fragment
scfv
mammalian
cell
caus
reduct
viral
growth
viral
protein
level
significantli
reduc
transfect
cell
comparison
vector
transfect
cell
h
post
infect
result
indic
tight
bind
could
lead
reduct
viral
replic
releas
progeni
viru
futur
antibodi
combin
neutral
antibodi
use
increas
potenc
viral
inhibit
influenza
viru
iav
member
orthomyxovirida
famili
still
threat
human
health
burden
health
servic
salomon
webster
despit
mani
advanc
iav
still
challeng
scientist
iav
highli
contagi
caus
agent
season
flu
epidem
result
morbid
mortal
huge
econom
loss
base
circul
strain
season
influenza
vaccin
develop
annual
biannual
need
immun
provid
shortliv
due
continu
chang
viru
strain
therefor
vaccin
usual
requir
everi
year
protect
season
flu
lead
increas
vaccin
cost
along
shortag
vaccin
develop
countri
two
main
problem
vaccin
time
requir
select
manufactur
deliv
vaccin
variabl
annual
immun
rate
couch
besid
vaccin
antivir
agent
therapeut
option
treat
infect
antivir
protein
neuraminidas
avail
irrat
use
led
emerg
resist
strain
agraw
et
al
hayden
hay
poland
et
al
thu
continu
requir
new
antivir
agent
iav
nonstructur
protein
iav
multifunct
protein
associ
variou
viral
function
includ
mrna
process
regul
via
interact
cleavag
http
elsevi
bv
right
reserv
abbrevi
iav
influenza
viru
nonstructur
rbd
rna
bind
domain
cleavag
polyadenyl
specif
factor
phosphoinositid
ifn
interferon
pkr
protein
kinas
r
oa
synthetas
dsrna
doublestrand
rna
mab
monoclon
antibodi
polyadenyl
specif
factor
inhibit
cellular
apoptosi
interact
regulatori
subunit
phosphoinositid
limit
interferon
ifn
product
ifninduc
protein
protein
kinas
r
pkr
oligoadenyl
synthetas
oa
rnase
l
bind
doublestrand
rna
dsrna
hale
et
al
min
krug
inhibit
mrna
splice
bind
snrna
qiu
et
al
wang
krug
two
function
distinct
domain
ntermin
rna
bind
domain
rbd
consist
three
ahelic
ctermin
effector
domain
consist
seven
bstrand
three
ahelic
rbd
domain
bind
low
affin
sever
rna
speci
sequenc
independ
manner
chien
et
al
hatada
fukuda
qian
et
al
effector
domain
predominantli
interact
hostcel
protein
also
function
stabil
rbd
domain
wang
et
al
well
conserv
protein
express
high
level
infect
cell
krug
etkind
pales
shaw
therefor
protein
good
target
therapeut
develop
sever
small
molecul
found
inhibit
function
result
reduc
viral
replic
engel
nayak
et
al
woo
et
al
previou
studi
gener
panel
new
monoclon
antibodi
mab
rna
bind
domain
rbd
report
biophys
character
one
mab
name
rbd
protein
interact
inhibit
viral
replic
target
protein
infect
cell
shown
bind
differ
iav
subtyp
name
mdck
cell
purchas
american
type
cultur
collect
manassa
va
usa
cell
line
cultur
co
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
apuerto
viru
obtain
american
type
cultur
collect
grown
embryon
chicken
egg
previous
describ
narasaraju
et
al
cdna
encod
gene
isol
genbank
access
number
clone
vector
ge
healthcar
uppsala
sweden
glutathion
stransferas
gst
fuse
protein
express
escherichia
coli
novagen
emd
chemic
inc
madison
wi
usa
purifi
previous
describ
gstfusion
protein
use
immun
mice
gener
hybridoma
previous
describ
oh
et
al
protocol
approv
institut
anim
care
use
committe
iacuc
biolog
resourc
centr
star
singapor
protocol
number
procedur
carri
strict
accord
recommend
nation
advisori
committe
laboratori
anim
research
naclar
guidelin
singapor
effort
made
minim
suffer
euthanasia
perform
use
carbon
dioxid
ascit
produc
inject
hybridoma
cell
periton
caviti
pristineprim
balbc
mice
protocol
approv
institut
anim
care
use
committe
iacuc
biolog
resourc
centr
star
singapor
protocol
number
procedur
carri
strict
accord
recommend
naclar
guidelin
singapor
effort
made
minim
suffer
euthanasia
perform
use
carbon
dioxid
gene
encod
nterminu
aa
achicken
clone
modifi
express
vector
novagen
ntermin
hissumo
tag
wildtyp
rbd
mutant
express
e
coli
rilp
overnight
protein
express
induc
use
mm
isopropyl
bdthiogalactosid
iptg
cell
harvest
centrifug
cell
pellet
resuspend
lysi
buffer
follow
pass
cell
disruptor
wwwavestincom
five
time
ultracentrifug
rpm
h
supernat
load
onto
ninta
affin
column
purif
pool
elut
fraction
dialys
overnight
dialysi
buffer
mm
tri
ph
mm
nacl
supplement
proteas
hissumo
cleavag
fraction
reload
onto
ninta
affin
column
remov
hissumo
tag
flow
load
onto
hiload
superdex
column
ge
healthcar
equilibr
mm
tri
ph
mm
nacl
mm
dtt
purif
purifi
protein
dialys
dialysi
buffer
concentr
mgml
amicon
purifi
fragment
subject
tricinesdspag
gel
stain
use
coomassi
blue
visual
puriti
protein
antibodi
purifi
ascit
hitrap
protein
column
ge
healthcar
accord
manufactur
instruct
briefli
ascit
dilut
phosphat
buffer
salin
pb
inject
preequilibr
protein
column
whole
antibodi
elut
column
use
mm
glycin
ph
elut
buffer
subject
papain
cleavag
accord
manufactur
instruct
brief
whole
antibodi
incub
immobil
papain
thermo
scientif
digest
buffer
mm
sodium
phosphat
ph
mm
edta
mm
cystein
overnight
follow
fab
purif
hitrap
protein
l
column
ge
healthcar
accord
manufactur
instruct
faruv
cd
spectra
nm
record
use
jasco
spectropolarimet
jasco
corpor
tokyo
japan
cuvett
chamber
instrument
optic
continu
purg
l
nitrogenmin
measur
spectra
record
use
scan
speed
nmmin
resolut
nm
bandwidth
nm
rbd
lm
lm
dissolv
mm
phosphat
buffer
ph
place
cuvett
cm
path
length
averag
three
scan
taken
increas
signal
nois
ratio
baselin
subtract
rbd
mix
ratio
incub
overnight
rbd
complex
format
examin
gel
filtrat
chromatographi
hiload
superdex
column
ge
healthcar
sampl
inject
column
equilibr
mm
tri
ph
buffer
contain
mm
nacl
elut
buffer
use
akta
purifi
system
ge
healthcar
life
scienc
piscataway
nj
usa
flow
rate
mlmin
gel
filtrat
fraction
analyz
sdspage
readi
gel
biorad
affin
rbd
rbd
bind
antibodi
determin
use
ge
healthcar
life
scienc
piscataway
nj
usa
briefli
antibodi
lg
ml
dilut
mm
sodium
acet
buffer
ph
immobil
flow
rate
llmin
min
surfac
chip
ge
healthcar
follow
standard
carbodiimid
edc
plu
nhydroxysuccinimid
nh
ge
healthcar
coupl
chemistri
kinet
measur
carri
min
inject
flow
rate
llmin
serial
dilut
rbd
rbd
hbsep
buffer
ge
healthcar
nm
lm
respect
dissoci
min
immobil
chip
surfac
regener
inject
mm
glycin
ph
flow
rate
llmin
cycl
data
collect
process
use
biaevalu
softwar
ge
healthcar
bind
concentr
seri
rbd
rbd
analyz
use
bind
model
data
correct
subtract
buffer
control
well
zero
antibodi
flow
cell
purifi
wildtyp
mutant
rbd
protein
dilut
differ
concentr
carbonatebicarbon
buffer
ph
protein
coat
onto
elisa
plate
nunc
overnight
well
block
milk
pb
tween
pbst
h
follow
addit
whole
antibodi
lgml
primari
antibodi
well
incub
h
well
wash
pbst
follow
addit
goat
antimous
horseradish
peroxidas
hrp
conjug
antibodi
pierc
secondari
antibodi
incub
h
tetramethylbenzidin
substrat
pierc
ad
reaction
stop
use
sulfur
acid
absorb
nm
record
use
absorb
reader
tecan
infinit
variabl
heavi
v
h
variabl
light
v
l
gene
obtain
rna
extract
hybridoma
describ
previous
dang
et
al
monoclon
antibodi
target
spike
protein
sever
acut
respiratori
syndrom
sar
coronaviru
lip
et
al
subsequ
construct
use
overlap
pcr
link
via
gggsgggsggg
linker
final
clone
cmv
express
vector
flag
myc
epitop
fuse
n
terminu
plasmid
transfect
confluent
cell
use
xtreme
gene
hp
roch
accord
manufactur
instruct
h
h
posttransfect
cell
rins
use
pb
inocul
h
viral
media
collect
titrat
plaqu
assay
transfect
cell
lyse
lysi
buffer
mm
tri
ph
mm
nacl
h
cell
lysat
subsequ
collect
cell
lysat
lg
resolv
use
electrophoresi
sdspolyacrylamid
gel
transfer
nitrocellulos
membran
biorad
antibodi
flag
sigma
myc
santa
cruz
describ
bactin
sigma
use
wash
membran
incub
hrpconjug
secondari
antibodi
pierc
membran
wash
enhanc
chemiluminesc
substrat
pierc
ad
detect
use
mp
imag
system
biorad
mdck
cell
seed
plate
h
incub
plate
rins
use
pb
subsequ
adsorb
serial
dilut
supernat
contain
virus
h
medium
discard
cell
rins
use
pb
cell
overlaid
ml
dmem
supplement
agar
lgml
tpcktrypsin
thermo
scientif
incub
day
cell
fix
use
formalin
h
stain
use
crystal
violet
solut
twotail
student
test
appli
evalu
statist
signific
differ
measur
data
set
obtain
independ
experi
p
consid
statist
signific
order
character
interact
mab
protein
rbd
protein
express
e
coli
purifi
obtain
ascit
fluid
papain
cleavag
see
supplementari
fig
faruv
cd
spectroscopi
use
analyz
secondari
structur
rbd
spectrum
show
minima
nm
rbd
protein
fig
indic
rich
ahelic
consist
threedimension
structur
rbd
protein
hale
spectrum
show
minimum
nm
maximum
nm
fig
indic
compos
bsheet
structur
satow
et
al
tetin
et
al
next
rbd
mix
ratio
incub
overnight
subject
size
exclus
chromatographi
three
peak
obtain
separ
superdex
column
fig
rbd
protein
coelut
first
peak
free
elut
major
peak
fig
antibodi
bind
spike
protein
sar
coronaviru
lip
et
al
use
neg
control
experi
contrast
result
rbd
elut
column
separ
mixtur
run
superdex
column
see
supplementari
fig
result
clearli
indic
rbd
interact
elut
time
suggest
antibodyantigen
complex
molecular
weight
greater
kda
fig
dynam
light
scatter
dl
perform
fraction
contain
complex
result
reveal
homogen
estim
molecular
weight
kda
see
supplementari
fig
given
rbd
exist
dimer
kda
bind
kda
yield
expect
size
kda
assum
complex
globular
structur
may
impli
antigenantibodi
complex
actual
multimer
natur
occurr
multimer
antigenantibodi
complex
report
sever
studi
sanni
price
santora
et
al
howev
rule
complex
globular
structur
henc
show
nonid
chromatograph
behavior
indepth
studi
use
sophist
biophys
techniqu
like
nuclear
magnet
reson
need
get
better
insight
residu
previous
shown
requir
interact
sinc
sidechain
residu
make
direct
hydrogen
bond
doubl
strand
rna
dsrna
backbon
dsrna
bind
affin
reduc
either
mutat
cheng
et
al
two
substitut
mutant
rbd
rbd
gener
determin
residu
critic
interact
perform
compar
elisa
fig
result
show
rbd
rbd
bound
compar
antigen
concentr
test
bind
rbd
significantli
decreas
lgml
protein
use
coat
bind
bovin
serum
albumin
bsa
use
neg
control
observ
doubl
substitut
mutant
rbd
also
test
two
residu
lie
upstream
bind
domain
previous
shown
import
rna
bind
wang
et
al
rbd
mutant
similar
bind
rbd
confirm
residu
upstream
like
involv
interact
sinc
appear
play
key
role
rbd
interact
spr
next
use
compar
antibodybind
affin
rbd
rbd
antibodi
immobil
biosensor
chip
variou
concentr
rbd
rbd
pass
chip
kinet
associ
dissoci
record
spr
sensorgram
kinet
rate
constant
kon
koff
determin
ascend
rate
reson
unit
associ
descend
rate
dissoci
result
show
rbd
high
affin
k
nm
fig
wherea
rbd
significantli
lower
affin
k
lm
fig
indic
residu
import
strong
bind
cd
spectrum
rbd
reveal
secondari
structur
similar
rbd
fig
indic
substitut
caus
gross
structur
chang
sinc
bind
rbd
may
abil
inhibit
function
infect
cell
express
intracellularli
gene
clone
mammalian
express
plasmid
transient
transfect
cell
h
cell
inocul
moi
viru
amount
viru
secret
determin
plaqu
quantit
h
post
infect
hpi
shown
fig
viral
growth
transfect
cell
reduc
approxim
log
pfuml
hpi
compar
cell
transfect
vector
determin
viral
inhibit
specif
scfv
irrelev
antibodi
bind
spike
protein
sar
coronaviru
lip
et
al
also
use
experi
viral
growth
transfect
cell
show
reduct
compar
cell
transfect
vector
cell
transfect
data
shown
experi
repeat
use
highli
transfect
cell
follow
cell
infect
moi
harvest
hpi
western
blot
analysi
consist
result
obtain
cell
level
viral
protein
infect
cell
significantli
reduc
transfect
cell
compar
vector
transfect
cell
hpi
fig
c
averag
reduct
normal
express
transfect
cell
compar
vector
transfect
cell
hpi
respect
result
suggest
bind
could
hinder
role
infect
caus
reduct
viral
replic
releas
result
show
murin
mab
bind
tightli
protein
affin
interact
significantli
reduc
substitut
express
intracellularli
bind
express
infect
cell
caus
signific
reduct
viral
protein
express
releas
progeni
viru
sinc
sidechain
involv
rna
bind
cheng
et
al
like
bind
neg
impact
abil
bind
rna
henc
result
reduct
viral
replic
viabl
drug
target
involv
variou
process
crucial
viral
replic
propag
hale
et
al
past
small
chemic
compound
shown
inhibit
function
viru
replic
basu
et
al
walkiewicz
et
al
precis
mechan
action
chemic
compound
still
unknown
remain
elucid
earlier
function
bind
site
shown
inhibit
second
third
zinc
finger
residu
fragment
result
inhibit
iav
replic
without
detect
effect
cellular
function
twu
et
al
approach
express
cell
block
iav
replic
infect
similar
method
express
intracellularli
bind
inhibit
interact
interestingli
recent
public
also
report
abil
specifichuman
scfv
inhibit
replic
influenza
viru
yodsheewan
et
al
howev
mechan
bind
differ
bound
residu
respect
studi
open
new
opportun
restrict
viral
replic
target
differ
domain
via
differ
mode
inhibit
futur
studi
import
use
combin
differ
inhibit
molecul
determin
increas
potenc
viral
inhibit
andor
minim
chanc
viral
escap
vitro
vivo
deliveri
antibodi
scfv
cell
import
aspect
antivir
therapi
thu
viral
express
vector
adenoviru
lentiviru
use
deliveri
moreov
cytoplasm
transduct
peptid
ctp
stretch
basic
residu
extens
document
effici
deliveri
biomolecul
gump
dowdi
kim
et
al
recent
hepat
b
viru
replic
report
inhibit
intracellular
deliveri
scfv
core
protein
via
ctp
xun
et
al
altern
viral
express
vector
fuse
ctp
effici
cytoplasm
transloc
scfv
cell
express
level
show
graph
normal
actin
experi
perform
triplic
averag
valu
standard
deviat
plot
differ
express
vector
transfect
cell
transfect
cell
evalu
unpair
ttest
p
p
